Saint Louis University School of Medicine, St. Louis, Missouri, USA.
Midwest Orthopaedics at Rush University Medical Center, Chicago, Illinois, USA.
Am J Sports Med. 2023 Dec;51(14):3858-3869. doi: 10.1177/03635465221150507. Epub 2023 Mar 6.
Elbow ulnar collateral ligament (UCL) injuries can result in significant functional impairment in throwing and overhead athletes. UCL reconstruction and repair are proven treatments to restore stability, but the efficacy of nonoperative management is unclear.
To determine the rate of return to sports (RTS) and return to previous level of play (RTLP) in athletes sustaining medial elbow ulnar collateral ligament (UCL) injuries treated nonoperatively.
Systematic review; Level of evidence, 4.
A literature search was performed using Scopus, PubMed, Medline, the Cochrane Database for Systematic Review, and the Cochrane Central Register for Controlled Trials according to the 2020 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. Inclusion criteria were limited to level 1 to 4 human studies reporting on RTS outcomes after nonoperative management of UCL injuries.
A total of 15 studies, consisting of 365 patients with a mean age of 20.45 ± 3.26 years, were identified. Treatment primarily consisted of platelet-rich plasma (PRP) injections with physical therapy (n = 189 patients; n = 7 studies) versus physical therapy alone (n = 176 patients; n = 8 studies). The overall RTS rate was 79.7% and the overall RTLP rate was 77.9%. Increasing UCL injury severity grade was associated with lower RTS rates. The RTS rate for proximal tears (89.7%; n = 61/68) was significantly greater than that for distal tears (41.2%; n = 14/34) ( < .0001). No significant difference in RTS rate was seen in patients treated with PRP versus those who did not receive PRP ( = .757).
For athletes undergoing nonoperative management of UCL injuries, the overall RTS and RTLP rates were 79.7% and 77.9%, respectively, with excellent outcomes in grade 1 and grade 2 UCL injuries, specifically. The RTS rate for proximal tears was significantly higher than that for distal tears. Athletes were most commonly treated with PRP injection and physical therapy.
肘尺侧副韧带(UCL)损伤可导致投掷和过头运动员的功能显著受损。UCL 重建和修复是恢复稳定性的有效治疗方法,但非手术治疗的效果尚不清楚。
确定接受非手术治疗的肘内侧 UCL 损伤运动员的重返运动(RTS)和重返先前运动水平(RTLP)的比率。
系统评价;证据水平,4 级。
根据 2020 年 PRISMA(系统评价和荟萃分析的首选报告项目)声明,使用 Scopus、PubMed、Medline、Cochrane 系统评价数据库和 Cochrane 对照试验中心注册库对文献进行了检索。纳入标准仅限于报告 UCL 损伤非手术治疗后 RTS 结果的 1 至 4 级人类研究。
共确定了 15 项研究,共纳入 365 名平均年龄为 20.45 ± 3.26 岁的患者。治疗主要包括富含血小板的血浆(PRP)注射联合物理治疗(n = 189 例;n = 7 项研究)与单纯物理治疗(n = 176 例;n = 8 项研究)。总体 RTS 率为 79.7%,总体 RTLP 率为 77.9%。UCL 损伤严重程度分级增加与 RTS 率降低相关。近端撕裂的 RTS 率(89.7%;n = 61/68)显著高于远端撕裂(41.2%;n = 14/34)(<.0001)。接受 PRP 治疗与未接受 PRP 治疗的患者 RTS 率无显著差异(=.757)。
对于接受 UCL 损伤非手术治疗的运动员,总体 RTS 和 RTLP 率分别为 79.7%和 77.9%,1 级和 2 级 UCL 损伤的结果尤其出色。近端撕裂的 RTS 率显著高于远端撕裂。患者最常接受 PRP 注射和物理治疗。